Psychiatric adverse drug reactions reported during a 10-year period in the Swedish pediatric population

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue 1, 2012, Pages 79-86

  Bygdell, Maria ^a   Brunlöf, Gertrud ^a   Wallerstedt, Susanna M ^a   Kindblom, Jenny M ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Adverse drug reactions; Children; Off label; Pediatric; Psychiatric; SWEDIS

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; GLUCOCORTICOID; ISOTRETINOIN; MELATONIN; MONTELUKAST; SEROTONIN UPTAKE INHIBITOR; VACCINE;

ACNE; ADOLESCENT; AGE DISTRIBUTION; AGGRESSIVENESS; AGITATION; ANXIETY; APATHY; ARTICLE; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONCENTRATION LOSS; CONFUSION; DEPRESSION; DRUG INDUCED DISEASE; EUPHORIA; EXCITEMENT; FEMALE; HALLUCINATION; HUMAN; HYPERACTIVITY; HYPOMANIA; INFANT; INSOMNIA; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MANIA; MENTAL DISEASE; MENTAL INSTABILITY; MOOD DISORDER; NEWBORN; NIGHTMARE; OFF LABEL DRUG USE; PERSONALITY DISORDER; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEX RATIO; SIDE EFFECT; SLEEP DISORDER; SLEEP WALKING; SUICIDE; SUICIDE ATTEMPT;

ADOLESCENT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGE FACTORS; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENTAL DISORDERS; OFF-LABEL USE; PHARMACEUTICAL PREPARATIONS; SEX FACTORS; SUICIDE; SWEDEN;

EID: 84855356997     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2265     Document Type: Article

References (46)

1. Clavenna A, Bonati M. Adverse drug reactions in childhood: a review of prospective studies and safety alerts. Arch Dis Child 2009; 94(9): 724-8.
2. Impicciatore P, Choonara I, Clarkson A, et al. Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 2001; 52(1): 77-83.
3. Kimland E, Rane A, Ufer M, et al. Paediatric adverse drug reactions reported in Sweden from 1987 to 2001. Pharmacoepidemiol Drug Saf 2005; 14(7): 493-9.
4. Clarkson A, Choonara I. Surveillance for fatal suspected adverse drug reactions in the UK. Arch Dis Child 2002; 87(6): 462-6.
5. Moore TJ, Weiss SR, Kaplan S, et al. Reported adverse drug events in infants and children under 2 years of age. Pediatrics 2002; 110(5): e53.
6. Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Pediatr 2005; 164(9): 552-8.
7. t Jong GW, Stricker BH, Choonar I, et al. Lack of effect of the European guidance on clinical investigation of medicines in children. Acta Paediatr 2002; 91(11): 1233-8.
8. Ufer M, Rane A, Karlsson A, et al. Widespread off-label prescribing of topical but not systemic drugs for 350, 000 paediatric outpatients in Stockholm. Eur J Clin Pharmacol 2003;58(11):779-83.
9. Choonara I, Conroy S. Unlicensed and off-label drug use in children: implications for safety. Drug Saf: Int J Med Toxicol Drug Exp 2002; 25(1): 1-5.
10. Horen B, Montastruc JL, Lapeyre-Mestre M. Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol 2002; 54(6): 665-70.
11. Ufer M, Kimland E, Bergman U. Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden. Pharmacoepidemiol Drug Saf 2004; 13(3): 147-52.
12. Turner S, Nunn AJ, Fielding K, et al. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr 1999; 88(9): 965-8.
13. Merchant RC, Damergis JA, Gee EM, et al. Contraceptive usage, knowledge and correlates of usage among female emergency department patients. Contraception 2006;74(3):201-7.
14. Sonnenberg FA, Burkman RT, Hagerty CG, et al. Costs and net health effects of contraceptive methods. Contraception 2004; 69(6): 447-59.
15. Busen NH, Britt RB, Rianon N. Bone mineral density in a cohort of adolescent women using depot medroxyprogesterone acetate for one to two years. J Adolescent Health: Ofcl pub Soc Adolescent Med 2003; 32(4): 257-9.
16. Aagaard L, Christensen A, Hansen EH. Information about adverse drug reactions reported in children: a qualitative review of empirical studies. Br J Clin Pharmacol 2010; 70(4): 481-91.
17. Aagaard L, Weber CB, Hansen EH. Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007. Drug Saf: Int J Med Toxicol Drug Exp 2010; 33(4): 327-39.
18. Sundstrom A, Alfredsson L, Sjolin-Forsberg G, et al. Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study. BMJ 341: c5812.
19. Hetrick S, Merry S, McKenzie J, et al. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents. Cochrane Database Syst Rev 2007; (3): CD004851.
20. Ronsley R, Elbe D, Smith DH, et al. Do Hospital and Community SSRI Usage Patterns in Children and Adolescents Match the Evidence? J Can Acad Child Adolesc Psychiatry 2010; 19(3): 218-26.
21. Wallerstedt SM, Brunlof G, Sundstrom A, et al. Montelukast and psychiatric disorders in children. Pharmacoepidemiol Drug Saf 2009; 18(9): 858-64.
22. de Vries TW, de Langen-Wouterse JJ, van Puijenbroek E, et al. Reported adverse drug reactions during the use of inhaled steroids in children with asthma in the Netherlands. Eur J Clin Pharmacol 2006; 62(5): 343-6.
23. World Health Organisation Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atc/structure-and-principles/ [retrieved 2011-05-17]
24. Neubert A, Wong IC, Bonifazi A, et al. Defining off-label and unlicensed use of medicines for children: results of a Delphi survey. Pharmacol Res 2008; 58(5-6): 316-22.
25. Wallerstedt SM, Brunlöf G, Sundström A. Rates of Spontaneous Reports of Adverse Drug Reactions for Drugs Reported in Children - A Cross-Sectional Study with Data from the Swedish Adverse Drug Reaction Database and the Swedish Prescribed Drug Register. Drug Safety 2011; in press.
26. Carleton BC, Smith MA, Gelin MN, et al. Paediatric adverse drug reaction reporting: understanding and future directions. Can J Clin Pharmacol 2007; 14(1): e45-57.
27. Leone R, Venegoni M, Motola D, et al. Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three italian regions. Drug Saf 2003; 26(2): 109-20.
28. Aagaard L, Hansen EH. Adverse drug reactions from psychotropic medicines in the paediatric population: analysis of reports to the Danish Medicines Agency over a decade. BMC Res Notes 2010; 3: 176.
29. Clark RC, Maxwell SR, Kerr S, et al. The influence of primary care prescribing rates for new drugs on spontaneous reporting of adverse drug reactions. Drug Saf: Int J Med Toxicol Drug Exp 2007; 30(4): 357-66.
30. Sundstrom A, Alfredsson L, Sjolin-Forsberg G, et al. Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study. BMJ 2010; 341: c5812.
31. Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 2007; 297(15): 1683-96.
32. Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 2006; 63(3): 332-9.
33. Sareen J, Cox BJ, Afifi TO, et al. Anxiety disorders and risk for suicidal ideation and suicide attempts: a population-based longitudinal study of adults. Arch Gen Psychiatry 2005;62(11):1249-57.
34. Graham J, Banaschewski T, Buitelaar J, et al. European guidelines on managing adverse effects of medication for ADHD. Eur. Child Adolesc psychiatr 2011; 20(1): 17-37.
35. Manalai P, Woo JM, Postolache TT. Suicidality and montelukast. Expert Opin Drug Saf 2009; 8(3): 273-82.
36. Kimland E, Bergman U, Lindemalm S, et al. Drug related problems and off-label drug treatment in children as seen at a drug information centre. Eur J Pediatr 2007; 166(6): 527-32.
37. Conroy S, Choonara I, Impicciatore P, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. ENDIC. BMJ 2000; 320(7227): 79-82.
38. Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child-Fetal 1999; 80(2): F142-4; discussion F4-5.
39. McIntyre J, Conroy S, Avery A, et al. Unlicensed and off label prescribing of drugs in general practice. Arch Dis Child 2000; 83(6): 498-501.
40. Schumock GT, Lee TA, Joo MJ, et al. Association between Leukotriene-Modifying Agents and Suicide: What is the Evidence? Drug Saf: Int J Med Toxicol Drug Exp 2011; 34(7): 533-44.
41. Sturkenboom MC, Verhamme KM, Nicolosi A, et al. Drug use in children: cohort study in three European countries. BMJ 2008; 337: a2245.
42. Capaldi VF, 2nd, Carr RB. Citalopram-induced hallucinations and delusions in a young adult. GHP 2010; 32(6): 648 e1-3.
43. Spigset O. Adverse reactions of selective serotonin reuptake inhibitors: reports from a spontaneous reporting system. Drug Saf: Int J Med Toxicol Drug Exp 1999; 20(3): 277-87.
44. Halevy A, Shuper A. Methylphenidate induction of complex visual hallucinations. J Child Neurol 2009; 24(8): 1005-7.
45. Porfirio MC, Giana G, Giovinazzo S, et al. Methylphenidate-induced visual hallucinations. Neuropediatrics 2011; 42(1): 30-1.
46. Backstrom M, Mjorndal T, Dahlqvist R. Under-reporting of serious adverse drug reactions in Sweden. Pharmacoepidemiol Drug Saf 2004; 13(7): 483-7.